DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,053 filers reported holding DANAHER CORPORATION in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,480,940 | +0.6% | 13,932 | +0.6% | 0.24% | -3.6% |
Q1 2024 | $3,459,843 | +4.4% | 13,855 | -3.3% | 0.25% | -6.4% |
Q4 2023 | $3,313,041 | -11.3% | 14,321 | -4.8% | 0.27% | -23.9% |
Q3 2023 | $3,733,807 | +4.4% | 15,050 | +1.0% | 0.35% | -1.4% |
Q2 2023 | $3,577,800 | -22.7% | 14,907 | -18.8% | 0.36% | -29.1% |
Q1 2023 | $4,625,762 | -32.3% | 18,353 | -28.8% | 0.50% | -38.5% |
Q4 2022 | $6,836,938 | -7.9% | 25,759 | -10.4% | 0.82% | -14.6% |
Q3 2022 | $7,427,000 | +1.9% | 28,755 | +0.1% | 0.96% | +2.1% |
Q2 2022 | $7,285,000 | -13.6% | 28,735 | -0.1% | 0.94% | +12.1% |
Q1 2022 | $8,436,000 | -8.7% | 28,758 | +2.4% | 0.83% | -13.8% |
Q4 2021 | $9,236,000 | +4.4% | 28,072 | -3.4% | 0.97% | -10.9% |
Q3 2021 | $8,846,000 | +17.2% | 29,058 | +3.3% | 1.09% | +8.3% |
Q2 2021 | $7,549,000 | +19.4% | 28,128 | +0.1% | 1.00% | +4.0% |
Q1 2021 | $6,323,000 | -5.9% | 28,094 | -7.2% | 0.96% | -17.5% |
Q4 2020 | $6,722,000 | -1.2% | 30,262 | -4.3% | 1.17% | -11.1% |
Q3 2020 | $6,806,000 | +21.0% | 31,606 | -0.6% | 1.31% | +2.6% |
Q2 2020 | $5,624,000 | +25.5% | 31,805 | -1.8% | 1.28% | +2.5% |
Q1 2020 | $4,483,000 | – | 32,389 | – | 1.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |